Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma

被引:48
|
作者
Yu, JunJie [1 ]
Mao, WeiPu [1 ]
Sun, Si [1 ]
Hu, Qiang [1 ]
Wang, Can [1 ]
Xu, ZhiPeng [1 ]
Liu, RuiJi [1 ]
Chen, SaiSai [1 ]
Xu, Bin [2 ]
Chen, Ming [2 ,3 ]
机构
[1] Southeast Univ, Coll Med, Nanjing, Peoples R China
[2] Southeast Univ, Dept Urol, Affiliated Zhongda Hosp, Nanjing, Peoples R China
[3] Southeast Univ, Dept Urol, Affiliated Lishui Peoples Hosp, Nanjing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
prognostic signature; The Cancer Genome Atlas; long non-coding RNA; kidney renal clear cell carcinoma; M6A; PARTIAL NEPHRECTOMY; NONCODING RNAS; EXPRESSION; CANCER;
D O I
10.3389/fonc.2021.663263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to construct an m6A-related long non-coding RNAs (lncRNAs) signature to accurately predict the prognosis of kidney clear cell carcinoma (KIRC) patients using data obtained from The Cancer Genome Atlas (TCGA) database. Methods The KIRC patient data were downloaded from TCGA database and m6A-related genes were obtained from published articles. Pearson correlation analysis was implemented to identify m6A-related lncRNAs. Univariate, Lasso, and multivariate Cox regression analyses were used to identifying prognostic risk-associated lncRNAs. Five lncRNAs were identified and used to construct a prognostic signature in training set. Kaplan-Meier curves and receiver operating characteristic (ROC) curves were applied to evaluate reliability and sensitivity of the signature in testing set and overall set, respectively. A prognostic nomogram was established to predict the probable 1-, 3-, and 5-year overall survival of KIRC patients quantitatively. GSEA was performed to explore the potential biological processes and cellular pathways. Besides, the lncRNA/miRNA/mRNA ceRNA network and PPI network were constructed based on weighted gene co-expression network analysis (WGCNA). Functional Enrichment Analysis was used to identify the biological functions of m6A-related lncRNAs. Results We constructed and verified an m6A-related lncRNAs prognostic signature of KIRC patients in TCGA database. We confirmed that the survival rates of KIRC patients with high-risk subgroup were significantly poorer than those with low-risk subgroup in the training set and testing set. ROC curves indicated that the prognostic signature had a reliable predictive capability in the training set (AUC = 0.802) and testing set (AUC = 0.725), respectively. Also, we established a prognostic nomogram with a high C-index and accomplished good prediction accuracy. The lncRNA/miRNA/mRNA ceRNA network and PPI network, as well as functional enrichment analysis provided us with new ways to search for potential biological functions. Conclusions We constructed an m6A-related lncRNAs prognostic signature which could accurately predict the prognosis of KIRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma
    Dou, Qian
    Gao, Shun
    Gan, Hua
    Kang, Zhao
    Zhang, Han
    Yang, Yichun
    Tong, Hang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma
    Huang, Yongsheng
    Guo, Wenyi
    Zeng, Yuan
    Wang, Xinrong
    Fan, Bohao
    Zhang, Ying
    Yan, Lei
    Gu, Gangli
    Liu, Zhao
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [23] Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma
    Yue, Dezhi
    Ren, Congzhe
    Li, Hu
    Liu, Xiaoqiang
    MEDICINE, 2024, 103 (39) : e39874
  • [24] Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
    Jing Chen
    Kun Yu
    Guansheng Zhong
    Wei Shen
    Cancer Cell International, 20
  • [25] Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma
    Li, Tinghao
    Tong, Hang
    Zhu, Junlong
    Qin, Zijia
    Yin, Siwen
    Sun, Yan
    Liu, Xudong
    He, Weiyang
    FRONTIERS IN MEDICINE, 2022, 8
  • [26] Identification of PLAUR-related ceRNA and immune prognostic signature for kidney renal clear cell carcinoma
    Wang, Yu
    Sun, Zhuolun
    Lu, Shuo
    Zhang, Xu
    Xiao, Chutian
    Li, Tengcheng
    Wu, Jieying
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
    Shen, Hong-Yu
    Zhang, Jin
    Xu, Di
    Xu, Zheng
    Liang, Ming-Xing
    Chen, Wen-Quan
    Tang, Jin-Hai
    Xia, Wen-Jia
    MEDICINE, 2023, 102 (15) : E33530
  • [28] A Novel Pyroptosis-Related lncRNAs Signature for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma and Its Associations with Immunity
    Tang, Xinfang
    Zhang, Anna
    Feng, Yuanyuan
    Su, Ying
    Wang, Xiaoyu
    Jiang, Feng
    Ma, Jianxin
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [29] Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer
    Lv, Wenchang
    Wang, Yichen
    Zhao, Chongru
    Tan, Yufang
    Xiong, Mingchen
    Yi, Yi
    He, Xiao
    Ren, Yuping
    Wu, Yiping
    Zhang, Qi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma
    Guo, Xudong
    Sun, Zhuolun
    Jiang, Shaobo
    Jin, Xunbo
    Wang, Hanbo
    AGING-US, 2021, 13 (06): : 8276 - 8289